AU534051B2 - Ergot alkaloid slow-release compositions - Google Patents
Ergot alkaloid slow-release compositionsInfo
- Publication number
- AU534051B2 AU534051B2 AU54031/79A AU5403179A AU534051B2 AU 534051 B2 AU534051 B2 AU 534051B2 AU 54031/79 A AU54031/79 A AU 54031/79A AU 5403179 A AU5403179 A AU 5403179A AU 534051 B2 AU534051 B2 AU 534051B2
- Authority
- AU
- Australia
- Prior art keywords
- slow
- release compositions
- ergot alkaloid
- ergot
- alkaloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1301978 | 1978-12-21 | ||
CH1302178 | 1978-12-21 | ||
CH1301978 | 1978-12-21 | ||
CH1302178 | 1978-12-21 | ||
CH56679 | 1979-01-19 | ||
CH56779 | 1979-01-19 | ||
CH56779 | 1979-01-19 | ||
CH56679 | 1979-01-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5403179A AU5403179A (en) | 1980-06-26 |
AU534051B2 true AU534051B2 (en) | 1984-01-05 |
Family
ID=27427929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54031/79A Ceased AU534051B2 (en) | 1978-12-21 | 1979-12-19 | Ergot alkaloid slow-release compositions |
Country Status (23)
Country | Link |
---|---|
AT (1) | AT372279B (sv) |
AU (1) | AU534051B2 (sv) |
CA (1) | CA1139222A (sv) |
CH (1) | CH642259A5 (sv) |
CY (1) | CY1330A (sv) |
DE (1) | DE2950154A1 (sv) |
DK (1) | DK154607C (sv) |
FI (1) | FI793888A (sv) |
FR (1) | FR2444463A1 (sv) |
GB (1) | GB2038181B (sv) |
HK (1) | HK37986A (sv) |
HU (1) | HU182577B (sv) |
IE (1) | IE49323B1 (sv) |
IL (1) | IL59003A (sv) |
IT (1) | IT1164029B (sv) |
KE (1) | KE3617D (sv) |
MY (1) | MY8500129A (sv) |
NL (1) | NL187229C (sv) |
NZ (1) | NZ192457A (sv) |
PH (1) | PH25178A (sv) |
PT (1) | PT70614A (sv) |
SE (1) | SE442265B (sv) |
WO (1) | WO1980001242A1 (sv) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE14379T1 (de) * | 1981-04-27 | 1985-08-15 | Haessle Ab | Pharmazeutisches praeparat. |
US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
HU192050B (en) * | 1983-04-22 | 1987-05-28 | Sandoz Ag | Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist |
DE3413955A1 (de) * | 1983-04-22 | 1984-10-25 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten |
NL194389C (nl) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager. |
GB8426922D0 (en) * | 1984-10-24 | 1984-11-28 | Sandoz Ltd | Galenic formulation |
AT388101B (de) * | 1985-02-05 | 1989-05-10 | Sandoz Ag | Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung |
CN1003978B (zh) * | 1987-09-05 | 1989-04-26 | 广州陈李济药厂 | 一种补脾益肠丸的制备工艺 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3432593A (en) * | 1963-09-18 | 1969-03-11 | Key Pharm Inc | Delayed and sustained release type pharmaceutical preparation |
DE2528257C2 (de) * | 1974-07-04 | 1986-02-13 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue galenische Zubereitung |
DE2546577B2 (de) * | 1975-10-17 | 1981-04-02 | Sandoz-Patent-GmbH, 7850 Lörrach | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
-
1979
- 1979-12-12 CH CH626380A patent/CH642259A5/de not_active IP Right Cessation
- 1979-12-12 DK DK529879A patent/DK154607C/da not_active IP Right Cessation
- 1979-12-12 WO PCT/CH1979/000160 patent/WO1980001242A1/de unknown
- 1979-12-12 SE SE7910227A patent/SE442265B/sv not_active IP Right Cessation
- 1979-12-12 FI FI793888A patent/FI793888A/fi not_active Application Discontinuation
- 1979-12-13 DE DE19792950154 patent/DE2950154A1/de active Granted
- 1979-12-18 NL NLAANVRAGE7909105,A patent/NL187229C/xx not_active IP Right Cessation
- 1979-12-19 AU AU54031/79A patent/AU534051B2/en not_active Ceased
- 1979-12-19 PT PT70614A patent/PT70614A/pt not_active IP Right Cessation
- 1979-12-19 CA CA000342212A patent/CA1139222A/en not_active Expired
- 1979-12-19 IE IE2471/79A patent/IE49323B1/en unknown
- 1979-12-19 CY CY1330A patent/CY1330A/xx unknown
- 1979-12-19 PH PH23436A patent/PH25178A/en unknown
- 1979-12-19 NZ NZ192457A patent/NZ192457A/xx unknown
- 1979-12-19 IL IL59003A patent/IL59003A/xx unknown
- 1979-12-19 GB GB7943633A patent/GB2038181B/en not_active Expired
- 1979-12-20 FR FR7931229A patent/FR2444463A1/fr active Granted
- 1979-12-20 AT AT0803679A patent/AT372279B/de active
- 1979-12-20 IT IT51153/79A patent/IT1164029B/it active
- 1979-12-20 HU HU79SA3216A patent/HU182577B/hu not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY129/85A patent/MY8500129A/xx unknown
-
1986
- 1986-03-18 KE KE3617BD patent/KE3617D/xx unknown
- 1986-05-22 HK HK379/86A patent/HK37986A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK154607C (da) | 1989-06-05 |
CH642259A5 (de) | 1984-04-13 |
IT7951153A0 (it) | 1979-12-20 |
DE2950154C2 (sv) | 1989-05-11 |
IL59003A (en) | 1982-12-31 |
KE3617D (en) | 1986-04-18 |
PH25178A (en) | 1991-03-27 |
NZ192457A (en) | 1983-06-17 |
ATA803679A (de) | 1983-02-15 |
MY8500129A (en) | 1985-12-31 |
FR2444463B1 (sv) | 1983-02-25 |
AU5403179A (en) | 1980-06-26 |
IT1164029B (it) | 1987-04-08 |
IE49323B1 (en) | 1985-09-18 |
DK529879A (da) | 1980-06-22 |
NL7909105A (nl) | 1980-06-24 |
HU182577B (en) | 1984-02-28 |
HK37986A (en) | 1986-05-30 |
AT372279B (de) | 1983-09-26 |
SE7910227L (sv) | 1980-06-22 |
PT70614A (fr) | 1980-01-01 |
SE442265B (sv) | 1985-12-16 |
GB2038181A (en) | 1980-07-23 |
WO1980001242A1 (en) | 1980-06-26 |
CY1330A (en) | 1986-06-27 |
CA1139222A (en) | 1983-01-11 |
GB2038181B (en) | 1983-05-11 |
DE2950154A1 (de) | 1980-07-10 |
FI793888A (fi) | 1980-06-22 |
NL187229C (nl) | 1991-07-16 |
IE792471L (en) | 1980-06-21 |
FR2444463A1 (fr) | 1980-07-18 |
DK154607B (da) | 1988-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU520754B2 (en) | Nasal ergot alkaloid compositions | |
AU536181B2 (en) | Derivatives of camptothecin | |
AU4551179A (en) | Polymer-polyol compositions | |
AU4344579A (en) | Nitro-bromo-alkanol compositions | |
AU529805B2 (en) | Xanthine compositions | |
AU524193B2 (en) | Clavulanic acid composition | |
AU508628B2 (en) | Ergot alkaloid compositions | |
AU526938B2 (en) | Eva composition | |
AU526954B2 (en) | Penicillin composition | |
AU537581B2 (en) | Ergoline derivatives | |
AU534051B2 (en) | Ergot alkaloid slow-release compositions | |
GB2056279B (en) | Dermatological compositions containing alkaloids | |
AU540812B2 (en) | Steroid alkaloids | |
AU523773B2 (en) | Benzodiazepine compositions | |
AU545645B2 (en) | Ergot alkaloid | |
AU530738B2 (en) | Fasciolicidal compositions | |
AU530974B2 (en) | Phosphoranyl nitrogen derivatives | |
AU525818B2 (en) | Ergot peptide alkaloid derivates | |
AU531211B2 (en) | Nalbuphine composition | |
AU4691379A (en) | Vinca alkaloids | |
AU6302180A (en) | Ergot alkaloid | |
SG49185G (en) | Pharmaceutical compositions containing an ergot alkaloid and heparin | |
AU512782B2 (en) | Compositions comprising heparin andan ergot alkaloid | |
AU529462B2 (en) | Bromination of ergot alkaloids | |
AU6468980A (en) | Ergoline derivatives |